FIELD: medicine, gastroenterology, pharmacy. SUBSTANCE: invention proposes the preparation that comprises an alkaline hydrolytic lignin, lactulose and bifidobacterium culture taken at the definite ratio. The preparation gives positive results in treatment of patients with disbacteriosis, oncological and allergic diseases, lipid metabolism disorder, viral and chronic hepatitis and metabolic toxicosis of any etiology. EFFECT: enhanced effectiveness. 1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PREPARATION FOR TREATMENT OF PATIENTS WITH GASTROENTERIC DISEASES | 1998 |
|
RU2131260C1 |
| METHOD OF MEDICINAL LIGNIN PRODUCING | 1998 |
|
RU2131262C1 |
| METHOD OF PREPARING MEDICINAL LIGNIN | 1998 |
|
RU2140279C1 |
| ENTEROSORBENT | 2005 |
|
RU2279278C2 |
| PHARMACEUTICAL PREPARATION FOR INTESTINE BIOCOENOSIS NORMALISATION | 2007 |
|
RU2351344C2 |
| COMPOSITE ENTEROSORBENT | 2011 |
|
RU2491941C1 |
| HEPATOPROTECTIVE PROBIOTIC AGENT | 2006 |
|
RU2310463C1 |
| VETERINARY PHARMACEUTICAL COMPOSITION AND METHOD (VERSIONS) FOR PREVENTION AND TREATMENT OF GASTROINTESTINAL DISEASES AND INTOXICATIONS OF VARIOUS AETIOLOGIES IN ANIMALS | 2009 |
|
RU2440121C2 |
| COMPOSITION FOR PREPARING READY MEDICINAL FORM OF ENTEROSORBENT, METHOD OF PREPARING READY MEDICINAL FORM OF ENTEROSORBENT AND METHOD OF PROPHYLAXIS AND TREATMENT OF GASTROENTERIC TRACT DISEASES | 1999 |
|
RU2167669C2 |
| ENTEROSORBENT AND METHOD OF ITS OBTAINING | 2012 |
|
RU2514050C2 |
